+Compare
TECH
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
10.21B

TECH Bio-Techne Corp Forecast, Technical & Fundamental Analysis

a biological products manufacturer

Industry Biotechnology
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for TECH with price predictions
07:00 PM EST Dec 06, 2023

TECH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for TECH turned positive on November 07, 2023. Looking at past instances where TECH's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 13, 2023. You may want to consider a long position or call options on TECH as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

TECH moved above its 50-day moving average on December 01, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TECH crossed bullishly above the 50-day moving average on December 04, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TECH advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 259 cases where TECH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TECH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TECH broke above its upper Bollinger Band on December 07, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.112) is normal, around the industry mean (20.710). P/E Ratio (42.480) is within average values for comparable stocks, (137.900). Projected Growth (PEG Ratio) (1.148) is also within normal values, averaging (7.704). Dividend Yield (0.005) settles around the average of (0.035) among similar stocks. P/S Ratio (9.132) is also within normal values, averaging (330.425).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TECH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sorrento Therapeutics (OTC:SRNEQ).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.3B. The market cap for tickers in the group ranges from 402 to 464.61B. NVO holds the highest valuation in this group at 464.61B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 6%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 25%. IVBT experienced the highest price growth at 1,413%, while AMPE experienced the biggest fall at -65%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -58%. For the same stocks of the Industry, the average monthly volume growth was -53% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 63
SMR Rating: 94
Profit Risk Rating: 94
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

TECH is expected to report earnings to rise 1.80% to 41 cents per share on February 06

Bio-Techne Corp TECH Stock Earnings Reports
Q4'23
Est.
$0.42
Q3'23
Missed
by $0.02
Q2'23
Est.
$0.55
Q1'23
Est.
$0.53
Q4'22
Missed
by $0.02
The last earnings report on October 31 showed earnings per share of 40 cents, missing the estimate of 43 cents. With 930.58K shares outstanding, the current market capitalization sits at 10.21B.
A.I.Advisor
published Dividends

TECH paid dividends on November 24, 2023

Bio-Techne Corp TECH Stock Dividends
А dividend of $0.08 per share was paid with a record date of November 24, 2023, and an ex-dividend date of November 09, 2023. Read more...
A.I. Advisor
published General Information

General Information

a biological products manufacturer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
614 McKinley Place N.E.
Phone
+1 612 379-8854
Employees
3050
Web
https://www.bio-techne.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRU4.060.13
+3.31%
Spruce Power Holding Corp
MIRM32.280.72
+2.28%
Mirum Pharmaceuticals
OSK98.800.14
+0.14%
Oshkosh Corp
FITBI25.57-0.06
-0.23%
Fifth Third Bancorp
CGEM8.10-0.03
-0.32%
Cullinan Oncology

TECH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with AXON. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
+3.09%
AXON - TECH
61%
Loosely correlated
+1.29%
ARRY - TECH
44%
Loosely correlated
+0.38%
MDGL - TECH
42%
Loosely correlated
-0.32%
VCYT - TECH
42%
Loosely correlated
-2.57%
CGEN - TECH
41%
Loosely correlated
-2.86%
More

Groups containing TECH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
+3.09%
biological
(undefined stocks)
71%
Closely correlated
+0.52%
biotechnology
(undefined stocks)
65%
Loosely correlated
+0.64%
drugs
(undefined stocks)
51%
Loosely correlated
+0.88%